🇺🇸 carboplatine in United States

1,054 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 170 reports (16.13%)
  2. Erythema — 139 reports (13.19%)
  3. Thrombocytopenia — 106 reports (10.06%)
  4. Hypotension — 105 reports (9.96%)
  5. Dyspnoea — 103 reports (9.77%)
  6. Diarrhoea — 97 reports (9.2%)
  7. Pancytopenia — 93 reports (8.82%)
  8. Acute Kidney Injury — 83 reports (7.87%)
  9. Pruritus — 81 reports (7.69%)
  10. Anaemia — 77 reports (7.31%)

Source database →

Other Other approved in United States

Frequently asked questions

Is carboplatine approved in United States?

carboplatine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for carboplatine in United States?

Central Hospital, Nancy, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.